Discharge Medication Use Post-Operatively in GU Cancer Patients

Part of paid clinical trials in Charlotte, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT06795087
Status
Recruiting
Apply to this trial

Conditions

  • Genitourinary Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Opioid Medication Disposal Education — OTHER
    Education on opioid medication disposal will be provided in the form of a pamphlet created by Atrium Health based on FDA resources and will be given to all participants at discharge (cystectomy, nephrectomy, prostatectomy) beginning in the second year, approximately 13 months from when the first participant is enrolled or until a minimum of 100 evaluable participants are enrolled in the pre-education cohort, whichever occurs last.

Study Details

The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.

Key Dates

Start date
Feb 21, 2025
Status verified
Jan 2026
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027

Study Design

Enrollment
684 participants (estimated)

Arms

  • Arm: Pre-Education Cohort
  • Arm: Post-Education Cohort

Primary Outcome Measure

Discharge opioids consumed in 30 days after discharge [ Time Frame: 30 days after discharge ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Levine Cancer InstituteCharlotteNorth Carolina28204
Margarita Dzhanumova
[email protected]
704-355-2000
Stephen Riggs, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Charlotte, NC

By research site
Levine Cancer Institute· Charlotte, NC

Related Studies